영문목차

Field medical teams bridge the gap between cutting-edge science and clinical practice, especially in the complex area of rare diseases.

These conditions present unique challenges, such as limited data, small and geographically dispersed patient populations, and a high unmet medical need. For field medical professionals, this means navigating scientific uncertainty, building deep relationships with specialists, and serving as advocates.

FirstWord spoke with Gillian Logan, head of medical, northern cluster at Kyowa Kirin, to discuss how field medical teams tackle the challenges within the rare disease space.

Key Questions Answered:

• What are the most pressing challenges field medical teams face when engaging with HCPs in the rare disease space?
• How does Kyowa Kirin tailor its medical affairs strategy to address the unique needs of rare disease communities?
• What role does RWE play in shaping field medical activities for rare diseases?
• How do field medical teams at Kyowa Kirin balance the need for scientific exchange with the emotional and advocacy aspects of rare disease care?
• What tools or technologies have proven most effective in supporting field medical teams in rare disease settings?
• How do you ensure consistency and quality in scientific communication across different regions and rare disease indications?
• Can you share examples of how Kyowa Kirin's field medical teams collaborate with patient advocacy groups or directly with patients?
• How do you incorporate the patient voice into field medical strategies and training?
• What specific competencies or training are essential for field medical professionals working in rare diseases compared with more common conditions?
• What innovations or trends do you foresee shaping the future of field medical affairs in rare diseases?

Methodology:

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.